PlumX Metrics
Embed PlumX Metrics

Bevacizumab combined with platinum-based chemotherapy in primary or relapsed ovarian cancer patients: Meta-analysis and literature to review.

Journal of family medicine and primary care, ISSN: 2249-4863, Vol: 12, Issue: 11, Page: 2797-2804
2023
  • 0
    Citations
  • 0
    Usage
  • 0
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Article Description

Earlier, patients with advanced ovarian cancer were treated with a combination of cytoreductive surgery and platinum-based chemotherapy, which had significant outcomes in the past until an increase in relapse and resistance to treatment, which led to the use or development of bevacizumab (a vascular endothelial growth factor inhibitor) in the treatment of primary or relapsed ovarian cancer.

Bibliographic Details

Tauseef, Abubakar; Zafar, Maryam; Abodunrin, Faith; Siddiqui, Sameed A H; Millner, Paul; Khan, Saber M; Teplitsky, Ella; Masih, Durva; Mirza, Muazzam; Mirza, Mohsin

Medknow

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know